129 related articles for article (PubMed ID: 6215425)
1. Cytopenia and T cell proliferation.
Beverley PC; Linch DC; Callard RE; Worman CP; Cawley JC
J Clin Immunol; 1982 Jul; 2(3 Suppl):135S-141S. PubMed ID: 6215425
[TBL] [Abstract][Full Text] [Related]
2. Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders.
Callard RE; Smith CM; Worman C; Linch D; Cawley JC; Beverley PC
Clin Exp Immunol; 1981 Mar; 43(3):497-505. PubMed ID: 7026093
[TBL] [Abstract][Full Text] [Related]
3. Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia.
Rümke HC; Miedema F; ten Berge IJ; Terpstra F; van der Reijden HJ; van de Griend RJ; de Bruin HG; von dem Borne AE; Smit JW; Zeijlemaker WP; Melief CJ
J Immunol; 1982 Jul; 129(1):419-26. PubMed ID: 6211484
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.
Bom-van Noorloos AA; Pegels HG; van Oers RH; Silberbusch J; Feltkamp-Vroom TM; Goudsmit R; Zeijlemaker WP; von dem Borne AE; Melief CJ
N Engl J Med; 1980 Apr; 302(17):933-7. PubMed ID: 6444696
[TBL] [Abstract][Full Text] [Related]
5. A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells.
Al-Sakkaf L; Pozzilli P; Sensi M; Irving WL; Bottazzo GF
Clin Exp Immunol; 1985 Dec; 62(3):594-9. PubMed ID: 2935341
[TBL] [Abstract][Full Text] [Related]
6. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.
Landay A; Gartland GL; Clement LT
J Immunol; 1983 Dec; 131(6):2757-61. PubMed ID: 6227665
[TBL] [Abstract][Full Text] [Related]
8. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
Perl A; Gonzalez-Cabello R; Gergely P
J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
[TBL] [Abstract][Full Text] [Related]
9. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
[TBL] [Abstract][Full Text] [Related]
11. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.
Jones BM
Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842
[TBL] [Abstract][Full Text] [Related]
12. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
Tilden AB; Abo T; Balch CM
J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
[TBL] [Abstract][Full Text] [Related]
13. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
Brouet JC
N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6968035
[No Abstract] [Full Text] [Related]
14. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
15. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
16. Induction of a T-cell mediated suppressor activity by soluble products from antigen-specific helper/inducer human T-cell lines.
Fischer A; Beverley P; Feldmann M; Smith S
Immunology; 1983 Jan; 48(1):177-86. PubMed ID: 6217152
[TBL] [Abstract][Full Text] [Related]
17. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
[TBL] [Abstract][Full Text] [Related]
18. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
19. Generation of CFU-c suppressor T cells in vitro. IV. effect of time on the inhibitory activity of mitogen-primed normal T lymphocytes.
Podesta M; Frassoni F; Van Lint MT; Piaggio G; Giordano D; Cerri R; Marmont A; Bacigalupo A
Thymus; 1982 Jul; 4(4):233-42. PubMed ID: 6216634
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
Ault KA; Smith BR; Holmberg LA
N Engl J Med; 1980 Oct; 303(15):881-2. PubMed ID: 6968034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
